Search Results

One policeman and one driver: Both need more information about marijuana-impaired driving. CMMI offers some answers . Every day some 28 fatalities will be caused by impaired driving: As the number of states approve adult-use cannabis consumption, impairment goes up 40% of traffic crashes are alcohol-related; but 9-12% of crashes are cannabis-related Current law enforcement field detection of MJ relies on blood-alcohol measurements CMMI is dedicated to connecting the gap between theory and reality-- to Save Lives!​ Cannabis impairment is most critical in the first 2-3 hours. Starting Fall, 2022, we invite your group to join us in south Denver's unique MJ Impairment Simulator and Human Lab for Safe Subject Study on Cannabis Behavioral and BioLogical Impacts led by qualified Denver university specialists. Understanding the interplay between THC and alcohol, and THC and other substances offers new insight into realizing key connections. CMMI provides resources for • Courts & Evidence • Law Enforcement • Prosecuting & Defending Attorneys • Traffic Safety Experts • State Regulators & Lawmakers • University Researchers • Forensic Toxocoligists • Behavior Experts • Cannabis Advocates • MedMJ Patients • Press & Media • Global DataBases The Major 55 Studies and Journal Articles on Cannabis Impairment-- 2016 to present Arkel (2019) Per Se Failings Arkel/Lintzess (2021) Ashbridge (2012) "Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta= analysis" doi.10.1136/bmj.e536 Azagba Berg (2018) Bidwell Brady Brands Brown Burggren Burt Cavazos-Rehn Cole Compton Couper (2014) Covens Desrosiers (2015) Doroudgar(2018) Dubois Gelmi Ginsberg Gjerde (2016) Hartman / Brown Hartman/ Huestis Himes (2013) Hollis Huestis (1992) Karoly Lao (2020) Lynch (2020) Liquoris McCartney, Danielle (2021) Pearlson (2021) "Cannabis and Driving" doi.103389/fpsyt.2021.689444 Rameker/Berghaus (2004) Ramekers (2014) Ramaekers (2000) Robbe Rogeberg Rudisill (2014) Scott Stagner Thijssen Weinstein Wendell(2021) Whitehill (2018) https://www.frontiersin.org/articles/10.3389/fpsyt.2021.596601/full https://www.nhtsa.gov/drug-impaired-driving/understanding-how-marijuana-affects-driving CENTER FOR MANAGING MARIJUNA IMPAIRMENT No one else gets your email. You're invited to our monthly online-peer gathering.​ Get Email Can we save lives? Can we set a global standard for impairment? Will you help us lead the charge for fair and reliable THC impairment testing and analysis? 720-532-7364 Contact Us TESTIMONIALS

West420 Week brings MJ info! News moves fast in the cannabis space. Since 2015, we've been there-- get your free weekly email in box below Show more ``````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````` Newest CannaPlanna 2022 Sector Leaders in Cannabis & Hemp ​West420 calculated the relative market share of the top20 global cannabis leaders as the new year begins. Major mergers and acquisitions from this group will change the future MJ landscape forever, and that doesn't consider further interest from consumer packageds goods(CPG), liquor and beverage giants, pharma or the tobacco sector. Pressure on the (orange) Canadian group will accelerate, on the (red) next largest MSOS (multi-state operators) who join--or outgrow-- market leaders like Verano, Cresco or Columbia Care. Non-retail sectors in green further fill-out the major movers in cultivation, CBD (Charlottes's Web) and the soon-to-boom cannabis synthetics, as pioneered by GW Pharma. And privately-held firms--like PharmaCann/LivWell-- will also be targets, but global growth means new European corporations will be on this "word-map" soon. This weel's West420 NewsWeekly Immediate access to advanced business-to-business current topics from 40-plus global sources. Updated Weekly. Get Today's full CannaPlannaWeek clicking here : https://bit.ly/3FKSbH4 Library of Videos cannbis braintrust: the top 9 most-influential in global MJ - in their own words Boris - Kovlar - Rivers - John Lord - Hawkins - Bachtell - Services MJ Sector Evaluation Click this tex Strategic Planning Click this text to start editing. Use this space to describe your products and services to visitors. Double click the icons to choose one that represents the product or service you are highlighting. Complete Application Unit Click this text to start editing. Use this space to describe your products and services to visitors. Double click the icons to choose one that represents the product or service you are highlighting. Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Break up your content into different blocks to keep your page interesting. See More 1660 So. Albion #310 Denver, Colo 80140 Phone: 121 888 9876 Email: MedMJDenver@gmail.com Consulting Hotline: www.cHemp7.com

NewsMakers: Zip88 This is a direct collection of top features first reported in West420. Coming Soon: FDA and CBD/THC Service Name Less than 18% of all U.S. cannabis sales are provided by the top 12 MSOs. We bring you all the news from the MSOs (US & Canada) above, covering the latest news, analysis and projections for each company. ​ Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to edit the content and make sure to add any relevant information that you want to share with your visitors. People are genuinely interested in learning more about you, so don’t be afraid to share personal anecdotes to create a more friendly quality. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to edit the content and make sure to add any relevant information that you want to share with your visitors. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to edit the content and make sure to add any relevant information that you want to share with your visitors. People are genuinely interested in learning more about you, so don’t be afraid to share personal anecdotes to create a more friendly quality. Service Name This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content.

FDA v. CBD & THC - 2017 to 2023 The following press releases and statements of policy on CBD and cannabinoids follows the agency pronouncements on needed research, regulatory pathways and the Jan. 2023 notice saying the FDA had no mechanism for setting CD regulatory standards. Click Here t. Research by Steve Courneyer doi-- January 2023 FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward https://www.fda.gov/news-events/press-announcements/fda-concludes-existing-regulatory-frameworks-foods-and-supplements-are-not-appropriate-cannabidiol January 2023 FDA Issues Response to Three Citizen Petitions related to CBD and Dietary Supplements https://www.fda.gov/food/cfsan-constituent-updates/fda-issues-response-three-citizen-petitions-related-cbd-and-dietary-supplements November 2022 FDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBD --- https://www.fda.gov/food/cfsan-constituent-updates/fda-warns-companies-illegally-selling-food-and-beverage-products-contain-cbd May 2022 FDA Issues Warning Letters to Companies Illegally Selling CBD and Delta-8 THC Products ---- https://www.fda.gov/news-events/press-announcements/fda-issues-warning-letters-companies-illegally-selling-cbd-and-delta-8-thc-products FDA News Release March 2021 FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief https://www.fda.gov/news-events/press-announcements/fda-warns-companies-illegally-selling-over-counter-cbd-products-pain-relief FDA News Release December 2020 FDA Warns Companies Illegally Selling CBD Products https://www.fda.gov/news-events/press-announcements/fda-warns-companies-illegally-selling-cbd-products FDA News Release July 2020 FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease https://www.fda.gov/news-events/press-announcements/fda-approves-new-indication-drug-containing-active-ingredient-derived-cannabis-treat-seizures-rare FDA News Release April 2020 FDA Warns Companies Illegally Selling CBD Products to Treat Medical Conditions, Opioid Addiction 3/5/2020 – Statement: What You Need to Know (And What We’re Working to Find Out) About Products Containing Cannabis or Cannabis-derived Compounds, Including CBD The FDA is working to answer questions about the science, safety, and quality of products containing cannabis and cannabis-derived compounds, particularly CBD. Cannabis is a plant of the Cannabaceae family and contains more than eighty biologically active chemical compounds. The most commonly known compounds are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the component that produces the “high” associated with marijuana use. Much interest has been seen around CBD and its potential related to health benefits. Marijuana is different from CBD. CBD is a single compound in the cannabis plant, and marijuana is a type of cannabis plant or plant material that contains many naturally occurring compounds, including CBD and THC. The FDA has approved only one CBD product, a prescription drug product to treat seizures associated with Lennox Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in people one year of age and older. It is currently illegal to market CBD by adding it to a food or labeling it as a dietary supplement. The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason. Some CBD products are being marketed with unproven medical claims and are of unknown quality. The FDA will continue to update the public as it learns more about CBD. Potential harm, side effects and unknowns CBD has the potential to harm you, and harm can happen even before you become aware of it. CBD can cause liver injury. CBD can affect how other drugs you are taking work, potentially causing serious side effects. Use of CBD with alcohol or other drugs that slow brain activity, such as those used to treat anxiety, panic, stress, or sleep disorders, increases the risk of sedation and drowsiness, which can lead to injuries. Male reproductive toxicity, or damage to fertility in males or male offspring of females who have been exposed, has been reported in studies of animals exposed to CBD. CBD can cause side effects that you might notice. These side effects should improve when CBD is stopped or when the amount used is reduced. Changes in alertness, most commonly experienced as somnolence (drowsiness or sleepiness). Gastrointestinal distress, most commonly experienced as diarrhea and/or decreased appetite. Changes in mood, most commonly experienced as irritability and agitation. There are many important aspects about CBD that we just don’t know, such as: What happens if you take CBD daily for sustained periods of time? What level of intake triggers the known risks associated with CBD? How do different methods of consumption affect intake (e.g., oral consumption, topical , smoking or vaping)? What is the effect of CBD on the developing brain (such as on children who take CBD)? What are the effects of CBD on the developing fetus or breastfed newborn? How does CBD interact with herbs and other plant materials? Does CBD cause male reproductive toxicity in humans, as has been reported in studies of animals? https://www.fda.gov/news-events/press-announcements/fda-warns-companies-illegally-selling-cbd-products-treat-medical-conditions-opioid-addiction 3/5/20: FDA Advances Work Related to Cannabidiol Products with Focus on Protecting Public Health, Providing Market Clarity https://www.fda.gov/news-events/press-announcements/fda-advances-work-related-cannabidiol-products-focus-protecting-public-health-providing-market July 2019 FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety https://www.fda.gov/news-events/press-announcements/fda-warns-company-marketing-unapproved-cannabidiol-products-unsubstantiated-claims-treat-cancer FDA News Release July 2019 FDA is Committed to Sound, Science-based Policy on CBD https://www.fda.gov/news-events/fda-voices/fda-committed-sound-science-based-policy-cbd FDA Voices April 2019 Statement on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-new-steps-advance-agencys-continued-evaluation FDA Statement December 2018 Statement on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-signing-agriculture-improvement-act-and-agencys FDA Statement June 2018 Statement on the importance of conducting proper research to prove safe and effective medical uses for the active chemicals in marijuana and its components https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-importance-conducting-proper-research-prove-safe-and FDA Statement June 2018 FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-comprised-active-ingredient-derived-marijuana-treat-rare-severe-forms FDA News Release April 2019 Departing FDA Head Brings "Concern", Hope to CBD "Mass Market" Rules by Lloyd Covens, Editor, West420 www.CHemp7.com In a whirl-wind of activity, outgoing Food and Drug Administration commissioner Scott Gottlieb delivered headlines--and industry heartburn-- with actions and comments on CBD marketing claims https://www.linkedin.com/pulse/departing-fda-head-brings-concern-hope-cbd-mass-market-covens?trk=article-ssr-frontend-pulse_more-articles_related-content-card November 1, 2017 FDA warns companies marketing unproven products, derived from marijuana, that claim to treat or cure cancer https://www.fda.gov/news-events/press-announcements/fda-warns-companies-marketing-unproven-products-derived-marijuana-claim-treat-or-cure-cancer Press Releases at the FDA This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. List Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. List Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. List Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. List Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors.

Page Title This is a Paragraph. Click on "Edit Text" or double click on the text box to start editing the content and make sure to add any relevant details or information that you want to share with your visitors. Click Here Section Title Every website has a story, and your visitors want to hear yours. This space is a great opportunity to give a full background on who you are, what your team does and what your site has to offer. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know. If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement.

Click to Add Title Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Click to Add Title Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Click to Add Title Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Click to Add Title Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Circle K In Deal with GTI -- Millions Pour Into Pro-MJ Campaigns -- https://us20.campaign-archive.com/?u=a29ae9fc82523d3dffc3e0535&id=a818c2b2fbcle Students Demonstrate at White House for more Biden Pardons-- FDA Woodcock's Cannabis Oversight View https://us20.campaign-archive.com/?u=a29ae9fc82523d3dffc3e0535&id=ee9b6a876e Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Break up your content into different blocks to keep your page interesting. Click Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Break up your content into different blocks to keep your page interesting. Click this text to start editing. This simple title and text block is great for welcome or explanatory text. When writing, try to keep things down to a few lines at a time. Break up your content into different blocks to keep your page interesting. Our Recent Work Video Title LPP, SSDP Demand Further Prisoner Pardons; Woodcock Vision for THC https://us20.campaign-archive.com/?u=a29ae9fc82523d3dffc3e0535&id=ee9b6a876e Video Title Double-click the video to edit it and enter a short description of the video here.

We Are Coming SOON Who We Are This is your About section. This space is a great opportunity to give a full background on who you are, what you do and what your site has to offer. Your users are genuinely interested in learning more about you, so don’t be afraid to share personal anecdotes to create a more friendly quality. Double click on the text box to start editing your content and make sure to add all the relevant details you want site visitors to know. If you’re a business, talk about how you started and share your professional journey. Explain your core values, your commitment to customers and how you stand out from the crowd. Add a photo, gallery or video for even more engagement. Get on the List Sign up to receive the first word when we go live. First Name Last Name Email Subscribe Thanks for submitting!

Full Report at: https://bit.ly/3JqM5O0 ​ WILL CURALEAF ADMIT ABRAMOVICH CONNECTIONS? Even as Britain sanctioned Russian oligarch Roman Abramovich --number 6 on the Russian billionaire list with a $12.3Bill. fortune-- this week, CuraLeaf again refused to offer any details on how the company's 2nd largest shareholder's proceeding in 2018-2020 investment of millions into Canadian stock exchange-traded public firm, CURLF. New York-born Boris Alekseyevich Jordan, CuraLeaf's 31% owner, spent the fall of last year raising millions for his other mega-company-- his 59%-owned Renaissance Insurance. With years of financial backing by EZRAV-- the Russian conglomerate owned by Abramovich-- a new $250Mil. public offering [not directly flowing to CuraLeaf] closed at the end of 2021. On the 2018-2020 possible CuraLeaf investments by oligarch Andrei Blokh-- Forbes list number 71 richest oligarch and 21% ownership in the cannabis firm--- CuraLeaf vice president for corporate communications, Tracy Brady wrote West420 News: "We do not provide details about specific shareholders that are not already in public." On Feb. 25th, the day after Russian invaded Ukraine, Jordan tweeted: "our second largest shareholder is Andrei Blokh, a successful retired CPG entrepreneur who is not active in the Company. Mr. Blokh is a U.S. citizen, who also holds a Russian passport," stating that no sanctions could be lodged against any CuraLeaf investor, repeatedly calling in his American-born status as sheilding him from any U.S. federal action against his assets. Jordan's tweet failed to mention that Blokh holds dual-citizenship as a naturalized American, and lives in Moscow, where he still is involved with several Abramovich-connected businesses. On May 3, CuraLeaf reported it’s 2021 results climbing to a record $1.2Bill (up 93%), indicating that both retail and wholesale revenue more than doubled to $860M and $347M from a year ago. While the company experienced a tough 4th quarter (sales were flat from prior year), CURLF promised new SELECT-branded products heading its 120+ stores in 11 states, with a projection that 2022 could reach the $1.5-$1.6Bil. level. In the 75 minute analyst voice call, never mentioning the Ukrainian war, Jordan said he expects to see the company expand with a planned start of adult-use in its three New Jersey MMJ stores by mid-May, will expand its Arizona footprint with the addition of Tryke Industries holdings, and will bring new efficiencies to extracted oil/edible products through its installing of a proprietary “ACE” processing system. On March 24, the New Jersey cannabis commission is slated to issue licenses for current state MMJ operators to expand into adult-use sales. The Bellmawr, NJ CuraLeaf MMJ store is seven miles over the Delaware River from downtown Philadelphia, a market of 1.6Million, with no RMJ access. But Barron's 2020 business report on the Blokh and Abramovich was examined in their article: "Deep Russian Roots." Said Barron's of CuraLeaf: "The company is the creation of Russian-heritage billionaires who are American citizens. Its chairman is Boris Jordan, a banking success who was integrally involved in Russia’s complicated capitalist transition. His major investment partner is Andrei Blokh, well known as a former business associate of Russian oligarch Roman Abramovich. Abramovich is chronicled in the popular press as the owner of England’s Chelsea Football Club and for his behemoth “superyachts.”..... For his part, Blokh grew immensely wealthy in Abramovich-tied oil deals and, of all things, milk products. His consolidation of the Russian dairy industry under the Unimilk umbrella and its subsequent 2010 sale in to Danone made him wealthy beyond most imaginations." Barrons continued its feature: " In an interview with Barron’s, Jordan was emphatic: Blokh’s old friendship aside, Abramovich has nothing to do with the company," said the CuraLeaf owner. West 420 reporters have been unsuccessful in gaining greater clarity over the 2017 purchase of Blokh’s Nevada-based cannabis company --House of Herbs -- which preceeded the reverse-stock issuance of the new "CuraLeaf" in 2018. The original Jordan twelve-percent investment in PalliaTech in 2017 from current executive/board member Joe Lusardi, led to renaming of the surviving entity as CuraLeaf. Lusardi has been instrumental in growing company assets in licenses in Maine, Massachusetts, New York and New Jersey. In reporting the Renaissance capital raise, Interfax (Dec. 20, 2021 ) detailed the participants in the new flow of millions to Jordan's all-digital insurance agency: " Credit Suisse, J.P.Morgan and VTB Capital acted as the joint global coordinators and joint bookrunners, BCS Global Markets was senior bookrunner and Renaissance Capital, Sberbank Tinkoff Bank and Sova Capital were joint bookrunners. The free float after the IPO was about 24%. The Sputnik Group of Jordan and his partners owns 38.3% of the insurer, Baring Vostok holds 13.7%, a company controlled by billionaire Roman Abramovich owns 9.7%, and his partners Alexander Abramov, Alexander Frolov and and Andrey Gorodilov control 7%, 3.5% and 3.2%, respectively." https://interfax.com/newsroom/top-stories/73421/ In the IPO offering, selling shareholders included Sputnik Management Services (and affiliate Holding Renaissance Insurance), which represents the group of investors led by Jordan; Baring Vostok through Notivia Ltd; companies owned by Evraz Plc billionaires Alexander Abramov and Alexander Frolov; and Andrey Gorodilov, who worked at Roman Abramovich’s oil producer Sibneft and was later deputy governor of Chukotka. Asked for comment on Jordan's chairman role at Renaissance, Brady wrote West 420 saying "Curaleaf does not represent the interests of Renaissance Insurance; please address questions to that company directly." We forwarded a request for comment to the Russian insurance firm at the email provided by CuraLeaf, and at press time had received no response. Here is Jordan's upbeat Dec., 2021 interview with CNBC on the all-digital insurance prospects: https://www.cnbc.com/video/2021/12/07/renaissance-insurance-we-are-one-of-the-largest-and-most-profitable-fintechs-in-the-world.html March 10's UK newspaper, The Guardian reported: " Abramovich was targeted because the government’s Office of Financial Sanctions Implementation suspected that a steel company he had effective control of, Evraz plc, supplied steel to the Russian military to produce tanks." As the owner of a major British soccer team, Abramovich has frantically looked for a new owner to sell the $2Bil.-plus valued franchise, but the UK sanction will halt any potential business with British companies. Abramovich was reported to be a close Putin ally for much of the former KGS's 22 years as the Russian ruler. ----photo here--- Above: On Feb. 25, New York investor, "Betting Bruiser" issued a $10,000 challenge to Jordan to declare support for Ukraine, as had been done earlier by CEO's at Truleive and Green Thumb Industries. The tweek(below) drew a quick response from Jordan who called Bruiser xenophobic, and called for diplomacy and "a peaceful resolution that protects the lives of all citizens on both sides of this conflict.” Below: MEDIA SAVVY JORDAN conducts another business cable interview from the newly purchased $14Mil. estate he purchased in Boca Raton, FL (bottom left) estate he acquired at end of 2021 for $14Mill. Bottom right: CuraLeaf co-founder Blokh. In April, 2019, Russia Business Today reported "Andrei Blokh was a long-time partner of Abramovich, being engaged in his oil business in the late 1990s, and in 1998 he headed oil company Sibneft. After the sale of Sibneft, Bloch took up Abramovich’s assets in the food industry, collecting Planet Management from disparate enterprises, and then together with a partner bought the dairy part of this business, Unimilk. In 2010, Unimilk announced a merger with the Danone division in Russia; until 2016, Bloch remained a major shareholder of the combined company." Full story at: https:// russiabusinesstoday.com/economy/andrei-bloch-uses-marijuana-business-to-get-back-on-list-of-richest-russians/ Part 1-- report from March 3, 2022...... A relentless pursuit of assets-- brands, retailers and grows--has pushed CuraLeaf to the number one spot in total cannabis revenues. But the billions which have poured into the company from Russian oligarchs and former friends of the executive chairman, will shave out the backing of one Russian billionaire and could be the start of a totally changed CuraLeaf. Boris Jordan, 52, may have thought his countless acquisitions--from buying SELECT in 2019 to absorbing NorthEast licenses with co-founder Joe Lusardi-- could thrive under the mantle of being a Canadian public company. But this week's Ukraine invasion--and response from Western allies to bring unprecedented financial sanctions-- is about to freeze assets of the 21%(down from 29%) owner of CuraLeaf, Russian oligarch Andrei Blokh, a close associate of Jordan. But other Russian oligarchs-- Ruben Vardanyanm and Roman Abramovich are likely to be examined for past funding of many mega-deals-- all likely to to put an unblinking glare on the entire CuraLeaf enterprise. Jordan's closely held SPUTNIK--an early supplier of CuraLeaf millions--is coming under government scrutiny as U.S. officials, according to sources, who want to close off all North American funds slated to be shared with Russian business ties. "No other cannabis firm has this kind of foreign investment profile," noted a senior cannabis DC source seeking anonymity to speak, adding: "Now with Putin's Ukraine invasion, American MJ consumers will have to decide if their spending with Curaleaf, Select or UKU may have been part of sending profits to Moscow," even as the world recoils at the Russian-initiated death and carnage ahead in the Ukrainian. But its will not stop with the secretive Jordan--or with Blokh--as the glare of financial reckoning beings to untangle the Russian sources of d of cash and control flowing into/out of Russia could ultimately lead to a disintegration of CuraLeaf-- also driven by new state regulators not interested in advancing the fortunes of such a oligarch-driven mega-cannabis MSO. The day after Putin's first attack on Ukraine, CuraLeaf released this tweet: " “Curaleaf is an American success story founded by Me! Pls stop spreading misinformation. I was born in the US and live and work in the US! Our shareholder Andrei Blokh is also a US citizen" -- but Blokh resides in Moscow full time. Later at week's end, the company released another statement, this one not directly quoting Jordan. "The speculation on social media that the company and its major shareholders and executives will somehow be subject to any US government economic sanctions now or in the future is incorrect." Of all top 25 MSOs, U.S. and Canadian owned companies have some foreign investors, but nothing on the scale of what Jordan has collected-- initially justified by the easy entry for CuraLeaf into gaining vertical licenses in Florida(37), Pennsylvania (12), Illinois (10), Arizona (9), Missouri (5) and four valuable verticals in New York, New Jersey, Connecticut and Michigan. (see map above) Massive U.S.-NATO nation sanctions are laser-focused on under-cutting access and movement of cash in-and-out of Russia--with a unknown number of additional Russian backers of CuraLeaf likely to see assets frozen. But the deeper story at CuraLeaf beginning to un-ravel is the long-term team which 31% owner Jordan has assembled to run the Boston/Vancouver based MSO. A New York-born American, Jordan's family raised him as a Russian speaker, reminded him of his lineage back to Alexander I, and led him to head to Russia in the late 1990s to be part of the collapse of communism, but start of new corruption as oligarchs (and Jordan himself) profited from selling off state-owned oil, gas, food, real estate and media in much of 200-2012. From the current CuraLeaf board of directors, Peter Derby founded Dialog Banks(1989) and Troika Dialog (1991-97) which later became the vehicle for $8-$9billion in outflows from Russia, post laundered. Some of those funds flowed to the control of Andray Rozov, who has been connected to a plan for $310Mil. going to Trump Tower Toronto, and a pre-Presidential plan for more millions to build Trump Tower Moscow. (See the "Troika Laundramat" story at https://www.icij.org/inside-icij/2019/03/troika-laundromat-reveals-russian-banks-8-8bn-offshore-scheme/ ) Karl Johansson, another CuraLeaf board member worked from 1995 to 2014 on various Russian financial posts, notably Ernst Young CIS' Moscow office, and as a director of an financial advisory for Ukraine, Kazatstan and Latvia. Jordan brought his long-time general counsel, Peter Laurence Clateman to Curaleaf in 2018, after Clateman's 15 year work at SPUTNIK, a key source of all first-hand data on Jordan's company dealings. Johansson is chair of Russian's Acra Ratings, and was a veteran of the early 200os "aluminum wars" which created mega-mineral firm, Untel Co Rusa. Another key exec., CuraLeaf senior vice president for business development Edward Kelenchuk, was another long-time investment insider at SPUTNIK. Each year Forbes compiles its list of Russian oligarchs, noting for 2021, Andrei Blokh now ranks number 71, with an estimated net worth growing to $1.9Bill., with stock holding in CuraLeaf that likely exceed $900Mil. in stock market cap. In 2019, Blokh's net worth of $905 million earned him the 101st spot on Forbes’ 2019 ranking published on Thursday. His former business partner, Roman Abramovich, placed 10th with a net worth of $12.4 billion. Forbes reported: "Andrei Blokh was a long-time partner of Abramovich, being engaged in his oil business in the late 1990s, and in 1998 he headed oil company Sibneft. After the sale of Sibneft, Bloch took up Abramovich’s assets in the food industry, collecting Planet Management from disparate enterprises, and then together with a partner bought the dairy part of this business, Unimilk." For the years when Jordan himself ventured to the post-USSR in the late 1990s, a lucrative series of his own role in privatizing Soviet assets meant connecting with many in or near Putin's trusted circle--and setting up his own mega-investment firm, SPUTNIK, which he still chairs today, along with Renaissance Insurance, a major Russian insurer. Other Russians have not been so fortunate to have their U.S. cannabis investment plans work out. A convuluted attempt to lock down Southern California retail licenses by Russian millionaire Dima Bosov ended with his "suspicious" death. And other Rudy Guilliani associates (Lev Parnas and others) attempted to gain entry into the Nevada cannabis industry with unsuccessful mega-dollar bribes to Nevada politicians. Other Russian investments into the U.S. cannabis sector are likely to also come to light, with sanctions digging deep into the past ten years. The Americans at CuraLeaf: Joe Lusardi saw his MJ metering device company, Pallia Tech, get an early 2017 investment of 12% from Jordan. Lusardi also founded the first MMJ dispensary in Maine, and was an early entrant into Massachusetts medical. His company was granted one of the precious New Jersey MMJ permits, and today he is active working to expand the CuraLeaf footprint in New York, Pennsylvania and New Jersey. PalliaTech was renamed CuraLeaf, and Lusardi is named as "co-founder" of CuraLeaf itself, although the subsequent purchases on Bloom, Tryke, Grass Roots and SELECT were the foundations that took CuraLeaf to see an expected $1.62Bil. in 2021 gross revenues. GrassRoots founder Matt Davin sits on CuraLeaf's board, having sold his major MSO holdings to Jordan, and Mitch Kahn also is a board member having been a co-founder of GrassRoots--a sale for $900Mil in 2019. See the extended OregonLive story here: https://www.oregonlive.com/business/2019/06/behind-portlands-blockbuster-marijuana-deal-a-russian-billionaire-cannabis-consolidation.html Reaching back for the Washington Post op-ed which in 2007, Jordan seemed to be looking for a kind word on why Putin had little hope of working with the West. Jordan reasoned: "They also see their stability compromised by American support for the Orange and Rose revolutions in the former Soviet Bloc nations and the rumblings of NATO expansion into Ukraine and Georgia. Russians once had high hopes for a partnership with the United States," even as Jordan​ worked on U.S.-Russian cooperation, adding "but today they look back on years of real and perceived transgressions and ask, “If these are allies, why do we want them?” Today, after going to Russia to brag about his roots to Alexander I, his fluent Russian, and his ability to move in the all-powerful Putin power group, Jordan this week reverted to his stance as am American citizen, placing doubt on any talk of sanctions on him or his executive team. "Sanctions are going to be deep and unrelenting-- Jordan's partner Blokh has a massive target on his back," noted another industry expert, "and getting Curaleaf money flows back to Moscow is about to become impossible." Much like a Russian nesting doll-- with each layer of interconnectivie only apparent after you open the next -- developments at CuraLeaf will yeild even further evidence of a massive flow of Russian oligarch cash. That West420 News coverage in part 2 next week. BELOW: CURALEAF Directors and Senior Management profiled. Compiled by TheOrigin Source. Coming up Thu, March 3rd Curaleaf Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call. March 3, 2022 -- 5:00 p.m. ET--Live Call: +1-888-317-6003 (U.S.), +1-866-284-3684 (Canada) or +1-412-317-6061 (In't) Passcode: 1618049 --- Webcast: https://ir.curaleaf.com/events Boycott for Boris? CuraLeaf chairman Boris Alekseyevich Jordan(left) has consumed more than a billion dollars since 2018 building up his goal to become the globe's largest cannabis firm. The source of m​ uch of that money is now under scrutiny having come from Russian business and oligarchs--many aligned with President Vladimir Putin. Will Putin's Ukraine invasion--and resulting sanctions-- rip apart the CURALEAF insider game plan-- and force a potential re-alignment of ownership? With 2021 revenues surpassing an estimated $1.5Bill., the map below profiles CuraLeaf holdings in 23 states: Ukraine Sanctions to Hit 21% CuraLeaf Owner May Also Target Jordan's 31 % A relentless pursuit of assets-- brands, retailers and grows--has pushed CuraLeaf to the number one spot in total cannabis revenues. But the billions which have poured into the company from Russian oligarchs and former friends of the executive chairman, will shave out the backing of one Russian billionaire and could be the start of a totally changed CuraLeaf. Boris Jordan, 52, may have thought his countless acquisitions--from buying SELECT in 2019 to absorbing NorthEast licenses with co-founder Joe Lusardi-- could thrive under the mantle of being a Canadian public company. But this week's Ukraine invasion--and response from Western allies to bring unprecedented financial sanctions-- is about to freeze assets of the 21%(down from 29%) owner of CuraLeaf, Russian oligarch Andrei Blokh, a close associate of Jordan. But other Russian oligarchs -- Ruben Vardanyanm and Roman Abramovich are likely to be examined for past funding of many mega-deals-- all likely to to put an unblinking glare on the entire CuraLeaf enterprise. Jordan's closely held SPUTNIK--an early supplier of CuraLeaf millions--is coming under government scrutiny as U.S. officials, according to sources, who want to close off all North American funds slated to be shared with Russian business ties. "No other cannabis firm has this kind of foreign investment profile," noted a senior cannabis DC source seeking anonymity to speak, adding: "Now with Putin's Ukraine invasion, American MJ consumers will have to decide if their spending with Curaleaf, Select or UKU may have been part of sending profits to Moscow," even as the world recoils at the Russian-initiated death and carnage ahead in the Ukrainian. But it will not stop with the secretive Jordan--or with Blokh -- as the glare of financial reckoning begins to untangle the Russian sources of cash and control flowing into/out of Russia could ultimately lead to a disintegration of CuraLeaf -- also driven by new state regulators not interested in advancing the fortunes of such a oligarch-driven mega-cannabis MSO. The day after Putin's first attack on Ukraine, CuraLeaf released this tweet: “Curaleaf is an American success story founded by Me! Pls stop spreading misinformation. I was born in the US and live and work in the US! Our shareholder Andrei Blokh is also a US citizen" -- but Blokh resides in Moscow full time. Later at week's end, the company released another statement, this one not directly quoting Jordan. "The speculation on social media that the company and its major shareholders and executives will somehow be subject to any US government economic sanctions now or in the future is incorrect." Of all top 25 MSOs, U.S. and Canadian-owned companies have some foreign investors, but nothing on the scale of what Jordan has collected-- initially justified by the easy entry for CuraLeaf into gaining vertical licenses in Florida(37), Pennsylvania (12), Illinois (10), Arizona (9), Missouri (5) and four valuable verticals in New York, New Jersey, Connecticut and Michigan. Massive U.S.-NATO nation sanctions are laser-focused on under-cutting access and movement of cash in-and-out of Russia--with a unknown number of additional Russian backers of CuraLeaf likely to see assets frozen. But the deeper story at CuraLeaf beginning to unravel is the long-term team which 31% owner Jordan has assembled to run the Boston/Vancouver-based MSO. A New York-born American, Jordan's family raised him as a Russian speaker, reminded him of his lineage back to Alexander I, and led him to head to Russia in the late 1990s to be part of the collapse of communism, but start of new corruption as oligarchs (and Jordan himself) profited from selling off state-owned oil, gas, food, real estate and media in much of 200-2012. From the current CuraLeaf board of directors, Peter Derby founded Dialog Banks(1989) and Troika Dialog (1991-97) which later became the vehicle for $8-$9billion in outflows from Russia, post-laundered. Some of those funds flowed to the control of Andray Rozov, who has been connected to a plan for $310M going to Trump Tower Toronto, and a pre-Presidential plan for more millions to build Trump Tower Moscow. (See the "Troika Laundramat" story at https://www.icij.org/inside-icij/2019/03/troika-laundromat-reveals-russian-banks-8-8bn-offshore-scheme/ ) Karl Johansson, another CuraLeaf board member worked from 1995 to 2014 on various Russian financial posts, notably Ernst Young CIS' Moscow office, and as a director of a financial advisory for Ukraine, Kazatstan and Latvia. Jordan brought his long-time general counsel, Peter Laurence Clateman to Curaleaf in 2018, after Clateman's 15-year work at SPUTNIK, a key source of all first-hand data on Jordan's company dealings. Johansson is chair of Russian's Acra Ratings, and was a veteran of the early 2000s "aluminum wars" which created mega-mineral firm, Untel Co Rusa. Another key exec., CuraLeaf senior vice president for business development Edward Kelenchuk, was another long-time investment insider at SPUTNIK. Each year, Forbes compiles its list of Russian oligarchs, noting for 2021, Andrei Blokh now ranks number 71, with an estimated net worth growing to $1.9B, with stock holding in CuraLeaf that likely exceed $900M in stock market cap. In 2019, Blokh's net worth of $905 million earned him the 101st spot on Forbes’ 2019 ranking published on Thursday. His former business partner, Roman Abramovich, placed 10th with a net worth of $12.4 billion. Forbes reported: "Andrei Blokh was a long-time partner of Abramovich, being engaged in his oil business in the late 1990s, and in 1998 he headed oil company Sibneft. After the sale of Sibneft, Bloch took up Abramovich’s assets in the food industry, collecting Planet Management from disparate enterprises, and then together with a partner bought the dairy part of this business, Unimilk. For the years when Jordan himself ventured to the post-USSR in the late 1990s, a lucrative series of his own role in privatizing Soviet assets meant connecting with many in or near Putin's trusted circle--and setting up his own mega-investment firm, SPUTNIK, which he still chairs today. Other Russians have not been so fortunate to have their U.S. cannabis investment plans work out. A convoluted attempt to lock down Southern California retail licenses by Russian millionaire Dima Bosov ended with his "suspicious" death. Other Rudy Guilliani associates (Lev Parnas and others) attempted to gain entry into the Nevada cannabis industry with unsuccessful megadollar bribes to Nevada politicians. Other Russian investments into the U.S. cannabis sector are likely to also come to light, with sanctions digging deep into the past 10 years. The Americans at CuraLeaf: Joe Lusardi saw his MJ metering device company, Pallia Tech, get an early 2017 investment of 12% from Jordan. Lusardi also founded the first MMJ dispensary in Maine, and was an early entrant into Massachusetts medical. His company was granted one of the precious New Jersey MMJ permits, and today, he is active working to expand the CuraLeaf footprint in New York, Pennsylvania, and New Jersey. PalliaTech was renamed CuraLeaf, and Lusardi is named as "cofounder" of CuraLeaf itself, although the subsequent purchases on Bloom, Tryke, Grass Roots and SELECT were the foundations that took CuraLeaf to see an expected $1.62Bil. in 2021 gross revenues. GrassRoots founder Matt Davin sits on CuraLeaf's board, having sold his major MSO holdings to Jordan, and Mitch Kahn also is a board member having been a co-founder of GrassRoots--a sale for $900M in 2019. See the extended OregonLive story here: https://www.oregonlive.com/business/2019/06/behind-portlands-blockbuster-marijuana-deal-a-russian-billionaire-cannabis-consolidation.html Reaching back for the Washington Post op-ed which in 2007, Jordan seemed to be looking for a kind word on why Putin had little hope of working with the West. Jordan reasoned: "They also see their stability compromised by American support for the Orange and Rose revolutions in the former Soviet Bloc nations and the rumblings of NATO expansion into Ukraine and Georgia. Russians once had high hopes for a partnership with the United States," even as Jordan worked on U.S.-Russian cooperation, adding "but today they look back on years of real and perceived transgressions and ask, “If these are allies, why do we want them?” Today, after going to Russia to brag about his roots to Alexander I, his fluent Russian, and his ability to move in the all-powerful Putin power group, Jordan this week reverted to his stance as an American citizen, placing doubt on any talk of sanctions on him or his executive team. "Sanctions are going to be deep and unrelenting -- Jordan's partner Blokh has a massive target on his back," noted another industry expert, "and getting Curaleaf money flows back to Moscow is about to become impossible." Much like a Russian nesting doll -- with each layer of interconnective only apparent after you open the next -- developments at CuraLeaf will yield even further evidence of a massive flow of Russian oligarch cash. That West420 News coverage in part 2 next week. BELOW: CURALEAF Directors and Senior Management profiled. Compiled by TheOrigin Source. Coming up Thu, March 3rd Curaleaf Fourth Quarter and Fiscal Year End 2021 Financial Results Conference Call. March 3, 2022 -- 5:00 p.m. ET--Live Call: +1-888-317-6003 (U.S.), +1-866-284-3684 (Canada) or +1-412-317-6061 (In't) Passcode: 1618049 --- Webcast: https://ir.curaleaf.com/events CuraLeaf Board Members and Executive Group West 420 NewsWeekly: Russians in the U.S. Cannabis Sector (published March 31, 2020) After weeks of speculation on 2018-2019 Russian investors backing MJ giant CuraLeaf, a global effort to bring a ceasefire in Ukraine has shed a watchful eye on Roman Abramovich, the $12Bil oligarch who now has been reported to be shuttling between Kiev, Moscow and Istanbul. Abramovich's lifelong friend is Andrei Blokh, 21% backer of CuraLeaf, who's role in the company has been shrouded by CuraLeaf p.r. spokeswoman refusing any comment. While sanctioned in the UK last month, Abramovich spent part of last fall helping CuraLeaf chairman Boris Jordan raise some of $250Mil flowing to Jordan-controlled Renaissance Insurance, Russia's largest. But Ukraine president Voldimire Zelensky has successfully appealed to the U.S. government not to also sanction Abramovich on hopes he can use his Putin contact to broker some conflict cease-fire, or at least, safe, bombing-proof "refugee corridors" for escape. Separately, a $1Mil. scheme to bribe Nevada candidates in attempts to gain (already-issued) Nevada licenses, last week the New York southern district for New York has charged Russian oligar​ch Andrei Muraviev. The charges follow a guilty plea delivered on related charges by Lev Parnes, an associate of Trump fixer Rudy Guiliani. In an earlier New York Times report, Muraviev reportedly put $1Mil. investment into a California cannabis management company, Venture Rebel, which helped run a San Francisco cannabis shop known as MediThrive. Details of the venture, outlined in a lawsuit filed in San Francisco County Superior Court, were first reported by McClatchy newspapers and Mother Jones. Russian business magazine, Vedomosti, in October, 2019 reported on eight Russian investment firms with interest in U.S. cannabis, especially for funding MJ testing labs. The Vedomisti reserach revealed: "Andrey Kukushkin, former vice president of Renaissance Investment Management, drew attention to the cannabis market in 2014. He first invested in drugstores in California and Nevada that were licensed to sell cannabis products for medical purposes. But he soon decided that a large-scale business could only be built through vertical integration. Kukushkin's Oasis Fund began growing cannabis, producing cannabis products under its own brand, and developing a distribution network in the United States. Kukushkin does not disclose investments. Today, the company's revenue has reached $60 million a year. It is expected to be profitable by 2021. True, and Confident Cannabis is still unprofitable. But about 1000 testing laboratories have already been connected to it, which will allow the company to become an infrastructural component of the new market." See the full story at: https://russiabusinesstoday.com/environment/russian-businessmen-investing-in-marijuana-business-worldwide-report/ A 2019 transaction saw a $2Mil investment into Colorado CBD firm, Pure Spectrum CBD, raised $2Mil from a Russian group led by Pavel Cherkashin's Mindrock. another And another investor group reported by Vedomisti newspaper found: " Andrey Kukushkin, former vice president of Renaissance Investment Management, drew attention to the cannabis market in 2014. He first invested in drugstores in California and Nevada that were licensed to sell cannabis products for medical purposes. But he soon decided that a large-scale business could only be built through vertical integration. Kukushkin's Oasis Fund began growing cannabis, producing cannabis products under its own brand, and developing a distribution network in the United States." ------------------------------------------------------------------------------------- https://us20.campaign-archive.com/?u=a29ae9fc82523d3dffc3e0535&id=f25bcfef02 Boris Jordan, Founder, CuraLeaf May, 2021-- Entering the European Market https://www.bloomberg.com/news/articles/2021-03-09/curaleaf-to-enter-european-cannabis-market-in-285-million-deal

Weekly Updates: D8-CBD News Today's Research Links -- from PubMed Harm reduction is a central component of public health. Although the legal environment is becoming more restrictive for delta-8-THC in comparison to delta-9-THC, results suggest that delta-8-THC may be equally effective for desired purposes of cannabis use and lower in undesirable or adverse effects. All policies and practices should be informed by empirical evidence. https://pubmed.ncbi.nlm.nih.gov/34797727/ ​ First Name Last Name Email Message Send Thanks for submitting! Weekly Updates: D8/CBD Report

There’s Nothing Here... We can’t find the page you’re looking for. Check the URL, or head back home. Go Home

The Major 55 Studies and Journal Articles on Cannabis Impairment-- Post 2014 Edit Here Edit Edit Edit Here Edit Edit Edit Here Edit Borst Edit Here Edit Edit Edit Here Edit Edit Edit Here Edit Edit Edit Here Edit Edit Edit Here Edit Edit